Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
A real path to helping people feel better and live longer
certificate of analysis available on request Research Applications Suitable Laboratory Uses for the Wolverine Stack Dual-phase musculoskeletal tissue repair pathway studies vascular/ECM phase (BPC-157) and cell migration/cytoskeletal phase (TB-500) Tendon, ligament, and muscle healing pathway research in pre-clinical models Angiogenesis and vascular network organisation studies VEGF, VEGFR2, ERK1/2 signalling Fibroblast migration, proliferation, and ECM stabilisation assays in vitro Stem and progenitor cell mobilisation and differentiation studies Anti-inflammatory cytokine pathway investigations TNF-, IL-6 modulation Collagen synthesis, fibre alignment, and tissue organisation quality research Monotherapy vs
The inclusion of vitamin C works in synergy with glutathione, supporting optimal absorption and further augmenting antioxidant benefits
BPC-157 PEN as a fragment of gastric protein BPC-157 derives from a protective protein named Body Protection Compound, naturally present in gastric juice
US$ 21.77
US$ 25.66
US$ 23.77
US$ 27.67
US$ 27.40
US$ 21.71
US$ 27.46